NCT03660072View on ClinicalTrials.gov

Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 31, 2022

Primary Completion Date

October 28, 2022

Study Completion Date

October 28, 2022

Conditions
Multiple Myeloma
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

05510

Local Institution, Seoul

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03660072 - Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter